Macquarie Group’s Halozyme HALO Stock Holding History

Macquarie Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,546,185	Closed	-$113M	–	1123
2025 Q3	$113M	Sell	1,546,185 -537,207	-26%	-$35.7M	0.13%	192
2025 Q2	$108M	Sell	2,083,392 -590,881	-22%	-$33.6M	0.13%	209
2025 Q1	$171M	Sell	2,674,273 -231,212	-8%	-$13.4M	0.21%	105
2024 Q4	$139M	Sell	2,905,485 -105,340	-3%	-$5.4M	0.17%	159
2024 Q3	$172M	Sell	3,010,825 -66,702	-2%	-$3.82M	0.19%	133
2024 Q2	$161M	Buy	3,077,527 +86,402	+3%	+$3.79M	0.18%	135
2024 Q1	$122M	Sell	2,991,125 -291,515	-9%	-$10.9M	0.14%	193
2023 Q4	$121M	Sell	3,282,640 -161,550	-5%	-$6.08M	0.14%	199
2023 Q3	$132M	Buy	3,444,190 +134,835	+4%	+$5.52M	0.17%	161
2023 Q2	$119M	Buy	3,309,355 +108,874	+3%	+$3.71M	0.14%	205
2023 Q1	$122M	Buy	3,200,481 +595,220	+23%	+$27.9M	0.15%	187
2022 Q4	$148M	Buy	2,605,261 +50,294	+2%	+$2.57M	0.18%	141
2022 Q3	$101M	Buy	2,554,967 +34,436	+1%	+$1.52M	0.12%	223
2022 Q2	$111M	Buy	2,520,531 +45,885	+2%	+$1.98M	0.12%	217
2022 Q1	$98.7K	Sell	2,474,646 -598,310	-19%	-$21.3M	0.08%	298
2021 Q4	$124M	Buy	3,072,956 +80,889	+3%	+$3.02M	0.1%	262
2021 Q3	$122M	Buy	2,992,067 +50,129	+2%	+$2.1M	0.1%	255
2021 Q2	$134M	Buy	2,941,938 +731,878	+33%	+$32.4M	0.11%	227
2021 Q1	$92.1M	Sell	2,210,060 -107,992	-5%	-$4.93M	0.13%	178
2020 Q4	$99M	Buy	2,318,052 +171,548	+8%	+$6.17M	0.14%	157
2020 Q3	$56.4M	Buy	2,146,504 +1,910,555	+810%	+$53.2M	0.1%	228
2020 Q2	$6.33M	Buy	235,949 +1,385	+0.6%	+$31.2K	0.01%	749
2020 Q1	$4.22M	Buy	234,564 +4,564	+2%	+$86.6K	0.01%	745
2019 Q4	$4.08M	Hold	230,000	–	–	0.01%	857
2019 Q3	$3.57M	Hold	230,000	–	–	0.01%	848
2019 Q2	$3.95M	Sell	230,000 -170,000	-43%	-$2.74M	0.01%	836
2019 Q1	$6.44M	Sell	400,000 -100,000	-20%	-$1.62M	0.01%	712
2018 Q4	$7.32M	Hold	500,000	–	–	0.01%	664
2018 Q3	$9.09M	Hold	500,000	–	–	0.01%	666
2018 Q2	$8.44M	Hold	500,000	–	–	0.01%	674
2018 Q1	$9.79M	Sell	500,000 -4,100	-0.8%	-$79.4K	0.02%	615
2017 Q4	$10.2M	Buy	504,100 +4,100	+0.8%	+$75.4K	0.02%	626
2017 Q3	$8.69M	Hold	500,000	–	–	0.02%	634
2017 Q2	$6.41M	Buy	500,000 +40,000	+9%	+$534K	0.01%	690
2017 Q1	$5.96M	Hold	460,000	–	–	0.01%	711
2016 Q4	$4.54M	Buy	460,000 +155,200	+51%	+$1.7M	0.01%	754
2016 Q3	$3.68M	Sell	304,800 -304,800	-50%	-$3.11M	0.01%	805
2016 Q2	$5.26M	Buy	609,600 +304,800	+100%	+$3.01M	0.01%	861
2016 Q1	$2.89M	Buy	+304,800	New	+$2.87M	0.01%	853

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group's HALO Position: Q4 2025 in Review

Macquarie Group sold out of Halozyme (HALO) in Q4 2025, closing a stake of 1,546,185 shares — an estimated $113M sold.

Macquarie Group first reported a position in HALO in Q1 2016 and held it in 39 quarters. The position peaked at $172M in Q3 2024. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Macquarie Group reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 1,546,185 Halozyme shares in Q4 2025, an estimated $113M.
Macquarie Group first reported a position in Halozyme in Q1 2016 and held it in 39 quarters.
Macquarie Group's Halozyme position peaked at $172M in Q3 2024.
617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.